Text Size
40 studies found for:    Open Studies | "Carcinoid Tumor"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe
Conditions: Carcinoma;   Neuroendocrine;   Non Functioning Neuroendocrine Tumors/NET;   Non Syndromic Neuroendocrine Tumors/NET;   Carcinoids;   Non Functioning
Intervention: Drug: Everolimus
22 Not yet recruiting 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors
Conditions: Pheochromocytoma;   Neuroblastoma;   Paraganglioma;   Medullary Thyroid Carcinoma;   Carcinoid Tumors
Intervention: Drug: 123I-meta-iodobenzylguanidine
23 Recruiting Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
Conditions: Neuroendocrine Tumors;   Carcinoid Tumors
Intervention: Drug: Pasireotide Long Acting Release (LAR)
24 Recruiting Safety and Efficacy of 68Ga-DOTA-tyr3-Octreotide
Conditions: Neuroendocrine Tumors;   Carcinoid Tumors;   Neuroblastoma;   Medulloblastoma
Intervention: Drug: 68Ga-DOTATOC PET/C
25 Recruiting Open Label Extension Study of Conatumumab and AMG 479
Conditions: Advanced Solid Tumors;   Carcinoid;   Colorectal Cancer;   Locally Advanced;   Lymphoma;   Metastatic Cancer;   Non-Small Cell Lung Cancer;   Sarcoma;   Solid Tumors
Interventions: Drug: FOLFOX6;   Biological: Conatumumab;   Biological: Ganitumab;   Biological: Bevacizumab
26 Not yet recruiting A Trial of AMG 386 and Temsirolimus in Advanced Solid Tumors
Condition: Malignant Solid Tumour
Interventions: Drug: AMG 386;   Drug: Temsirolimus
27 Not yet recruiting Randomized Phase III of PRRT Versus Interferon
Condition: Gastro-intestinal Neuroendocrine Tumors
Interventions: Drug: Interferon alpha-2b;   Drug: 177Lu-octreotate
28 Unknown † Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
Condition: Cancer
Interventions: Drug: oxaliplatin;   Procedure: management of therapy complications
29 Recruiting 68Ga-DOTATATE PET Scan in Neuroendocrine Cancer
Condition: Neuroendocrine Carcinoma
Intervention: Drug: 68Ga-DOTATATE PET scan
30 Recruiting Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas
Condition: Well-differentiated Non-pancreatic Neuroendocrine Carcinoma
Interventions: Drug: Axitinib;   Drug: Sandostatin LAR;   Drug: Placebo
31 Unknown † Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery
Conditions: Lung Cancer;   Metastatic Cancer
Interventions: Procedure: cryosurgery;   Procedure: positron emission tomography
32 Unknown † Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Conditions: Esophageal Cancer;   Head and Neck Cancer;   Lung Cancer;   Precancerous Condition
Interventions: Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: sputum cytology;   Procedure: biopsy
33 Unknown † DNA Analysis of Blood and Tissue From Patients With Lung Cancer
Condition: Lung Cancer
Interventions: Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: diagnostic laboratory biomarker analysis
34 Unknown † Comfort Level of Two Abdominal Compression Methods Used to Hold Patients Still While Undergoing Stereotactic Body Radiation Therapy for Lung Tumors
Condition: Lung Cancer
Interventions: Other: questionnaire administration;   Procedure: computed tomography;   Radiation: radiation therapy treatment planning/simulation
35 Unknown † External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Condition: Cancer
Interventions: Drug: indinavir sulfate;   Drug: ritonavir;   Radiation: radiation therapy
36 Recruiting Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs
Condition: Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System
Interventions: Drug: Pasireotide LAR followed by Pasireotide LAR + Everolimus;   Drug: Everolimus followed by Pasireotide LAR + Everolimus
37 Not yet recruiting Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Condition: Neoplasms
Interventions: Drug: Everolimus;   Drug: Sandostatin LAR Depot
38 Recruiting Capecitabine and Temozolomide for Neuroendocrine Cancers
Condition: Neuroendocrine Tumors
Intervention: Drug: Capecitabine and temozolomide
39 Recruiting Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: High Dose Indium-111 pentetreotide (Neuroendomedix)
40 Recruiting Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs
Condition: Acromegaly
Intervention: Other: Oral Glucose Tolerance Test (OGTT)
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page
† Indicates status has not been verified in more than two years